Search Here

An assembly of government health officials recently made public a reorganized guideline on the daily intake of aspirin which could be directly advantageous to individuals with a heart disease.

The U.S. Preventive Services Task Force gave the approval last Monday which strictly catered to an adult demographic age of 50 to 59 which collected date of test subjects lowering  their risk for a heart attack due to a low-dose daily intake of aspirin, according to CNN.

Subjects belonging to the data gathered were background checked for a 10 percent or greater 10-year cardiovascular disease risk rate, a greater than before chance bleeding, and a minimum life expectancy of 10 years.

An incidental finding during the study also promoted the health panel to concur that a daily dosage of aspirin on the age group of 60 to 69 is also beneficial but such a treatment such talks with one's physician.

The dosage of aspirin was also given an assessment on those with stroke and colon cancer and it promoted positive results.

Dr. Biswajit Kar the medical division chief at the Center for Advanced Heart Failure at Memorial Hermann Heart and Vascular Institute-Texas Medical Center pointed out to CNN their findings.

"These new findings from the task force provide a good evidence-based approach for managing a disease with therapy that has risks. Low-dose aspirin therapy has many proven benefits, including preventing heart attacks, strokes, and colorectal cancer."

A previous study in 2009 was also made public and apparently with the advancement in technology there was a huge contrast between the two recommendations. The authors have also made it a point to include that gender doesn't play a role when medicated with the painkiller. 

In related news, aspirin was also the main focus of a study that recommends the medication to help in the prevention of breast cancer, according to Daily Mail UK.

It was revealed in the study by UK scientists that one or two tablets per week of aspirin on the controlled group lessened the probability of acquiring the disease by as much as 50 percent.